MedPath

Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix

Phase 2
Terminated
Conditions
Cervical Cancer
Registration Number
NCT00006482
Lead Sponsor
Gynecologic Oncology Group
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine and cisplatin in treating patients who have refractory or recurrent cancer of the cervix.

Detailed Description

OBJECTIVES:

* Determine the antitumor activity of gemcitabine and cisplatin in patients with refractory or recurrent squamous cell carcinoma of the cervix.

* Determine the nature and degree of toxicity of this regimen in these patients.

OUTLINE: This is a multicenter study.

Patients receive cisplatin IV and gemcitabine IV over 1 hour on days 1 and 8. Treatment continues every 28 days in the absence of disease progression or unacceptable toxicity.

Patients are followed every 3 months for 2 years and then every 6 months for 3 years.

PROJECTED ACCRUAL: A total of 28-69 patients will be accrued for this study.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (34)

Rush-Presbyterian-St. Luke's Medical Center

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Tufts University School of Medicine

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Ireland Cancer Center

πŸ‡ΊπŸ‡Έ

Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Center

πŸ‡ΊπŸ‡Έ

Cleveland, Ohio, United States

Fox Chase Cancer Center

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Walter Reed Army Medical Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Tacoma General Hospital

πŸ‡ΊπŸ‡Έ

Tacoma, Washington, United States

Cooper Hospital/University Medical Center

πŸ‡ΊπŸ‡Έ

Camden, New Jersey, United States

University of Pennsylvania Cancer Center

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Simmons Cancer Center - Dallas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Abington Memorial Hospital

πŸ‡ΊπŸ‡Έ

Abington, Pennsylvania, United States

Milton S. Hershey Medical Center

πŸ‡ΊπŸ‡Έ

Hershey, Pennsylvania, United States

Tom Baker Cancer Center - Calgary

πŸ‡¨πŸ‡¦

Calgary, Alberta, Canada

Cancer Center at the University of Virginia

πŸ‡ΊπŸ‡Έ

Charlottesville, Virginia, United States

University of Mississippi Medical Center

πŸ‡ΊπŸ‡Έ

Jackson, Mississippi, United States

Cancer Center of Albany Medical Center

πŸ‡ΊπŸ‡Έ

Albany, New York, United States

Rational Therapeutics Inc.

πŸ‡ΊπŸ‡Έ

Long Beach, California, United States

Community Hospital of Los Gatos

πŸ‡ΊπŸ‡Έ

Los Gatos, California, United States

Chao Family Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Orange, California, United States

Albert B. Chandler Medical Center, University of Kentucky

πŸ‡ΊπŸ‡Έ

Lexington, Kentucky, United States

University of Illinois College of Medicine at Peoria

πŸ‡ΊπŸ‡Έ

Peoria, Illinois, United States

State University of New York Health Science Center at Brooklyn

πŸ‡ΊπŸ‡Έ

Brooklyn, New York, United States

Roswell Park Cancer Institute

πŸ‡ΊπŸ‡Έ

Buffalo, New York, United States

Schneider Children's Hospital at North Shore

πŸ‡ΊπŸ‡Έ

Manhasset, New York, United States

Memorial Sloan-Kettering Cancer Center

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Arthur G. James Cancer Hospital - Ohio State University

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

Lineberger Comprehensive Cancer Center, UNC

πŸ‡ΊπŸ‡Έ

Chapel Hill, North Carolina, United States

University of Oklahoma College of Medicine

πŸ‡ΊπŸ‡Έ

Oklahoma City, Oklahoma, United States

Comprehensive Cancer Center at Wake Forest University

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

University of Alabama at Birmingham Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

H. Lee Moffitt Cancer Center and Research Institute

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Indiana University Cancer Center

πŸ‡ΊπŸ‡Έ

Indianapolis, Indiana, United States

Duke Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Durham, North Carolina, United States

Barrett Cancer Center, The University Hospital

πŸ‡ΊπŸ‡Έ

Cincinnati, Ohio, United States

Β© Copyright 2025. All Rights Reserved by MedPath